Showing results (21-30 of 336) with videos related to
Sort By:
Pageof 34
Cardiovascular & Hematological Agents in Medicinal Chemistry|October 26, 2012
Rosuvastatin and diabetes: when the evidences talkVivencio Barrios, Carlos EscobarFundamental & Clinical Pharmacology|August 18, 2009
Combined therapy in the treatment of hypertensionCarlos Escobar, Vivencio BarriosExpert Review of Cardiovascular Therapy|March 20, 2009
Diabetes and hypertension: which is the best approach?Carlos Escobar, Vivencio BarriosAmerican Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|November 25, 2010
Aliskiren in the management of hypertensionVivencio Barrios, Carlos EscobarFuture Cardiology|May 15, 2013
Can dabigatran improve blood pressure control?Vivencio Barrios, Carlos EscobarInternational Journal of Cardiology|June 19, 2009
Renal function and coronary disease: not only in clinical trialsCarlos Escobar, Rocio Echarri, Vivencio BarriosObesity (Silver Spring, Md.)|February 6, 2010
Clinical profile and management of patients with hypertension and chronic ischemic heart disease according to BMIVivencio Barrios, Carlos Escobar, Alberto CalderónFundamental & Clinical Pharmacology|March 21, 2009
Importance of medication adherence from the ONTARGET and TRANSCEND points of viewVivencio Barrios, Carlos Escobar, Rocio EcharriExpert Review of Cardiovascular Therapy|September 18, 2007
Candesartan: from left ventricular hypertrophy to heart failure, a global approachVivencio Barrios, Carlos Escobar, Alberto CalderonCardiovascular Therapeutics|August 20, 2010
Atrial fibrillation and dabigatran: has the time come to use new anticoagulants?Carlos Escobar, Vivencio Barrios, David JimenezPageof 34